Objective: The relations between acoustic measures and their articulatory bases have rarely been tested in dysarthria but are important for diagnostic and treatment purposes. We tested the association between acoustic measures of F2 range and F2 slope with kinematic measures of tongue movement displacement and speed in individuals with amyotrophic lateral sclerosis (ALS) and healthy controls speaking at normal and slow rates. Relations between acoustic and kinematic measures and speech intelligibility were examined. Results: As healthy controls reduced their speaking rate, their F2 slopes and movement speeds decreased. In talkers with ALS, acoustic and kinematic variables were associated with changes in speaking rate, characteristic of disease progression. Participants with slow rate had shallower F2 slopes and slower movement speeds than those with normal rate. Relations between F2 range and tongue displacement were weaker. F2 slope, displacement, and duration were correlated with speech intelligibility most consistently. Conclusion: Findings suggested that F2 slope is a useful marker for tracking disease progression in ALS. F2 slope reflects changes in tongue function with disease progression and is linked to speech intelligibility. Changes in movement speed, however, might be the earliest sign of disease in the tongue.

1.
Lindblom BEF, Sundberg JEF: Acoustical consequences of lip, jaw, tongue, and larynx movement. J Acoust Soc Am 1971;50:1166–1179.
2.
Stevens KN: On the quantal nature of speech. J Phonet 1989;17:3–45.
3.
Stevens KN, House AS: Development of a quantitative description of vowel articulation. J Acoust Soc Am 1955;27:484–493.
4.
Mefferd AS, Green JR: Articulatory-to-acoustic relations in response to speaking rate and loudness manipulations. J Speech Lang Hear Res 2010;53:1206–1219.
5.
Tasko SM, Greilick K: Acoustic and articulatory features of diphthong production: a speech clarity study. J Speech Lang Hear Res 2010;53:84–99.
6.
Hirose H, Kiritani S, Sawashima M: Velocity of articulatory movements in normal and dysarthric subjects. Folia Phoniatr 1982;34:210–215.
7.
Kent RD, Netsell R, Bauer LL: Cineradiography assessment of articulatory mobility in the dysarthrias. J Speech Hear Disord 1975;40:467–480.
8.
Yunusova Y, Weismer G, Westbury JR, Lindstrom MJ: Articulatory movements during vowels in speakers with dysarthria and healthy controls. J Speech Lang Hear Res 2008;51:596–611.
9.
Rosen KM, Goozée JV, Murdoch BE: Examining the effects of multiple sclerosis on speech production: does phonetic structure matter? J Commun Disord 2008;41:49–69.
10.
Tjaden K, Wilding GE: Rate and loudness manipulations in dysarthria: acoustic and perceptual findings. J Speech Lang Hear Res 2004;47:766–783.
11.
Weismer G, Kent R, Hodge M, Martin R: The acoustic signature for intelligibility test words. J Acoust Soc Am 1988;84:1281–1291.
12.
Liss JM, Weismer G: Selected acoustic characteristics of contrastive stress production in control geriatric, apraxic, and ataxic dysarthric speakers. Clin Linguist Phon 1994;8:45–66.
13.
Ziegler W, von Cramon D: Vowel distortion in traumatic dysarthria: a formant study. Phonetica 1983;40:63–78.
14.
Kent RD, Kent JF, Weismer G, Martin RE: Relationships between speech intelligibility and the slope of second-formant transitions in dysarthric subjects. Clin Linguist Phon 1989;3:347–358.
15.
Kim Y, Weismer G, Kent RD, Duffy JR: Statistical models of F2 slope in relation to severity of dysarthria. Folia Phoniatr Logop 2009;61:329–335.
16.
Hartelius L, Schalling E, Krull D, Lindblom B: Formant transitions in ataxic speech: the shape and speed of formant trajectories in individuals with multiple sclerosis and control speakers. J Med Speech-Lang Pathol 2010;18:54–60.
17.
Weismer G: Assessment of articulatory timing; in Cooper JA (ed): Assessment of Speech and Voice Production. Research and Clinical Applications. Bethesda, National Institutes of Health, 1991, vol 1, pp 84–95.
18.
Duffy JR: Motor Speech Disorders: Substrates, Differential Diagnosis, and Management. Philadelphia, Elsevier, 2005.
19.
Yorkston KM, Strand E, Miller R, Hillel A, Smith K: Speech deterioration in amyotrophic lateral sclerosis: implications for the timing of intervention. J Med Speech-Lang Pathol 1993;1:35–46.
20.
Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A, BDNF ALS Study Group: The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999;169:13–21.
21.
Beukelman D, Yorkston K, Hakel M, Dorsey M: Speech Intelligibility Test, Computer software. Lincoln, Madonna Rehabilitation Hospital, 2007.
22.
Turner GS, Tjaden K, Weismer G: The influence of speaking rate on vowel space and speech intelligibility for individuals with amyotrophic lateral sclerosis. J Speech Lang Hear Res 1995;38:1001–1013.
23.
Dromey C, Nissen S, Nohr P, Fletcher SG: Measuring tongue movements during speech: adaptation of a magnetic jaw tracking system. Speech Commun 2006;48:463–473.
24.
Yunusova Y, Giannakeas V, Green J: Using JT-3D (jaw tracker) for the acquisition of tongue movement. Department of Speech-Language Pathology, University of Toronto, 2010, Tech Rep 1.
25.
Milenkovic PH: TF32, Computer software. Madison, University of Wisconsin, 2001.
26.
Roberts KJ, Monaco JP: Effect size measures for the two-level linear multilevel model. Annu Meet Am Educ Res Assoc, Mississippi, 2006.
27.
Kuehn DP, Moll KL: A cineradiographic study of VC and CV velocities. J Phon 1976;4:303–320.
28.
Perkell JS, Zandipour M, Matthies ML, Lane H: Economy of effort in different speaking conditions. I. A preliminary study of intersubject differences and modeling issues. J Acoust Soc Am 2002;112:1627–1641.
29.
Smith A, Kleinow J: Kinematic correlates of speaking rate changes in stuttering and normally fluent adults. J Speech Lang Hear Res 2000;43:521–536.
30.
Tasko SM, McClean MD: Variations in articulatory movement with changes in speech task. J Speech Lang Hear Res 2004;47:85–100.
31.
Tjaden K, Weismer G: Speaking-rate-induced variability in F2 trajectories. Speech Lang Hear Res 1998;41:976–989.
32.
Gay T: Effect of speaking rate on diphthong formant movements. J Acoust Soc Am 1968;44:1570–1573.
33.
Dolan WB, Mimori Y: Rate-dependent variability in English and Japanese complex vowel F2 transitions. UCLA Working Papers in Phonetics 1986;63:125–153.
34.
Ball LJ, Beukelman DR, Pattee GL: Communication effectiveness of individuals with amyotrophic lateral sclerosis. J Commun Disord 2004;37:197–215.
35.
Weismer G, Yunusova Y, Bunton K: Measures to evaluate the effects of DBS on speech production. J Neurolinguist, in press.
36.
Stevens K: Acoustic Phonetics. Current Studies in Linguistics. Cambridge, MIT Press, 2000.
37.
Yunusova Y, Green JR, Lindstrom MJ, Ball LJ, Pattee GL, Zinman L: Kinematics in disease progression in bulbar ALS. J Commun Disord 2010;43:6–20.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.